Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-04-16 @ 6:40 AM
Study NCT ID:
NCT02840760
Status:
UNKNOWN
Last Update Posted:
2018-02-26
First Post:
2016-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.
Sponsor:
Shanghai Mental Health Center
Organization:
Study Overview
Official Title:
Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.
Status:
UNKNOWN
Status Verified Date:
2017-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to explore the therapeutic effect and mechanism of transcranial magnetic stimulation (rTMS) in the treatment of the tardive dyskinesia.
Detailed Description:
The study was a parallel control design trial for 2 weeks. Patients with schizophrenia were treated with 10-Hz rTMS on left motor cortex (added to the ongoing treatment). Clinical symptoms and MEP were assessment before and after rTMS treatment.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: